Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125244302 | 12524430 | 2 | F | 20151120 | 20160718 | 20160704 | 20160802 | EXP | GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-119629 | RANBAXY | 51.00 | YR | F | Y | 62.00000 | KG | 20160802 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125244302 | 12524430 | 1 | PS | Atorvastatin | ATORVASTATIN | 1 | Unknown | 10 MG, DAILY | U | 76477 | 10 | MG | |||||||
| 125244302 | 12524430 | 2 | SS | Atorvastatin | ATORVASTATIN | 1 | Unknown | 40 MG, DAILY | U | 76477 | 40 | MG | |||||||
| 125244302 | 12524430 | 3 | C | KEPPRA | LEVETIRACETAM | 1 | Unknown | U | U | 0 | 4000 | MG | |||||||
| 125244302 | 12524430 | 4 | C | FRISIUM | CLOBAZAM | 1 | Unknown | AS NECESSARY | U | U | 0 | ||||||||
| 125244302 | 12524430 | 5 | C | TEGRETOL XR | CARBAMAZEPINE | 1 | Unknown | U | U | 0 | 1400 | MG | |||||||
| 125244302 | 12524430 | 6 | C | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | 1000 MG, QID | U | U | 0 | 1000 | MG | Q6H | |||||
| 125244302 | 12524430 | 7 | C | ZONISAMIDE. | ZONISAMIDE | 1 | Unknown | 200MG MORNING, 100MG MIDDAY, 200MG NOCTE | U | U | 0 | 500 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125244302 | 12524430 | 1 | Product used for unknown indication |
| 125244302 | 12524430 | 2 | Product used for unknown indication |
| 125244302 | 12524430 | 3 | Product used for unknown indication |
| 125244302 | 12524430 | 4 | Product used for unknown indication |
| 125244302 | 12524430 | 5 | Product used for unknown indication |
| 125244302 | 12524430 | 6 | Product used for unknown indication |
| 125244302 | 12524430 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125244302 | 12524430 | HO |
| 125244302 | 12524430 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125244302 | 12524430 | Amnesia | |
| 125244302 | 12524430 | Asthenia | |
| 125244302 | 12524430 | Balance disorder | |
| 125244302 | 12524430 | Change in seizure presentation | |
| 125244302 | 12524430 | Dizziness | |
| 125244302 | 12524430 | Epilepsy | |
| 125244302 | 12524430 | Fatigue | |
| 125244302 | 12524430 | Influenza like illness | |
| 125244302 | 12524430 | Muscle rigidity | |
| 125244302 | 12524430 | Muscular weakness | |
| 125244302 | 12524430 | Nasopharyngitis | |
| 125244302 | 12524430 | Paralysis | |
| 125244302 | 12524430 | Speech disorder | |
| 125244302 | 12524430 | Syncope | |
| 125244302 | 12524430 | Tonic clonic movements | |
| 125244302 | 12524430 | Vision blurred | |
| 125244302 | 12524430 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125244302 | 12524430 | 1 | 20151120 | 0 | ||
| 125244302 | 12524430 | 2 | 20160503 | 0 |